Isoforms of NO-sensitive guanylyl cyclase

被引:62
|
作者
Russwurm, M [1 ]
Koesling, D [1 ]
机构
[1] Ruhr Univ Bochum, Med Fak MA N1, D-44780 Bochum, Germany
关键词
nitric oxide; NO-sensitive guanylyl cyclase; PDZ domain; cGMP;
D O I
10.1023/A:1014252309493
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
By the formation of cGMP the NO-sensitive guanylyl cyclase plays a key role within the NO/cGMP signaling cascade involved in vascular regulation and neurotransmission. The prosthetic heme group of the enzyme acts as the NO sensor, and binding of NO induces conformational changes leading to an up to 200-fold activation of the enzyme. The unexpected fast dissociation half-life of NO of a few seconds is fast enough to account for the deactivation of the enzyme in biological systems. YC-1 and its analogues acting as NO sensitizers uncovered a new pharmacologically and conceivably physiologically relevant regulatory principle of the enzyme. Two existing isoforms of the heterodimeric guanylyl cyclase (alpha(1)beta(1), alpha(2)beta(1)) are known that are functionally indistinguishable. Up to now, the NO-sensitive guanylyl cyclase has been considered as a soluble enzyme. However, recent evidence about the alpha(2)beta(1) isoform interacting with a PDZ domain of the postsynaptic scaffold protein PSD-95 suggests that the alpha(2) subunit directs a membrane association of this isoform. The interaction with PSD-95 locates the alpha(2)beta(1) isoform in close proximity to the NO-generating NO synthase thereby enabling the NO sensor to respond to locally raised NO concentrations.
引用
收藏
页码:159 / 164
页数:6
相关论文
共 50 条
  • [21] Deletion of NO-sensitive guanylyl cyclase in smooth muscle is sufficient to cause hypertension
    Groneberg, D.
    Koenig, P.
    Koesling, D.
    Friebe, A.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2008, 377 : 22 - 22
  • [22] Guanylyl cyclase/PSD-95 interaction:: Membrane-association of the α2β1 isoform of NO-sensitive guanylyl cyclase?
    Russwurm, M
    Reimers, K
    Wittau, N
    Koesling, D
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2001, 363 (04) : R44 - R44
  • [23] Contribution of NO-sensitive guanylyl cyclase isoformis α1β1 and α2β1 to vasodilation
    Mergia, E
    Friebe, A
    Dangel, O
    Koesling, D
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2005, 371 : R38 - R38
  • [24] Major occurrence of the new α2β1 isoform of NO-sensitive guanylyl cyclase in brain
    Mergia, E
    Russwurm, M
    Zoidl, G
    Koesling, D
    CELLULAR SIGNALLING, 2003, 15 (02) : 189 - 195
  • [25] Arterial stiffness and pulse wave velocity in mice lacking NO-sensitive guanylyl cyclase
    Duennes, S.
    Groneberg, D.
    Herold, V.
    Jakob, P.
    Friebe, A.
    ACTA PHYSIOLOGICA, 2016, 216
  • [26] Differential role of NO-sensitive guanylyl cyclase isoforms NO-GC1 and NO-GC2 in auditory function in adult mice
    Dorit Möhrle
    Nicole Eichert
    Steffen Wolter
    Evanthia Mergia
    Doris Koesling
    Andreas Friebe
    Marlies Knipper
    Lukas Rüttiger
    BMC Pharmacology and Toxicology, 16 (Suppl 1)
  • [27] NO-sensitive guanylyl cyclase expression discriminates two types of myofibroblasts in lung fibrosis
    Englert, Nils
    Aue, Annemarie
    Schmidtko, Achim
    Groneberg, Dieter
    Friebe, Andreas
    JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17 (01)
  • [28] Phosphodiesterase 3A expression and activity in the murine vasculature is influenced by NO-sensitive guanylyl cyclase
    Sarah Dünnes
    Barbara Voussen
    Annemarie Aue
    Kaja Groneberg
    Viacheslav Nikolaev
    Dieter Groneberg
    Andreas Friebe
    Pflügers Archiv - European Journal of Physiology, 2018, 470 : 693 - 702
  • [29] Inhibition of deactivation of NO-sensitive guanylyl cyclase accounts for the sensitizing effect of YC-1
    Russwurm, M
    Mergia, E
    Mullershausen, F
    Koesling, D
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (28) : 24883 - 24888
  • [30] Lack of effect of ODQ does not exclude cGMP signalling via NO-sensitive guanylyl cyclase
    Lies, Barbara
    Groneberg, Dieter
    Gambaryan, Stepan
    Friebe, Andreas
    BRITISH JOURNAL OF PHARMACOLOGY, 2013, 170 (02) : 317 - 327